AMA's Recent Approval Marks a Milestone for Innoblative's SIRA Device in Breast Cancer Treatment Innoblative's SIRA® device receives an important CPT code approval from AMA, paving the way for enhanced treatment options in breast cancer care.

AMA's Recent Approval Marks a Milestone for Innoblative's SIRA Device in Breast Cancer Treatment #USA #Chicago #Breast_Cancer #Innoblative #SIRA_Device

Innoblative's Innovative Device Gains Approval for Breast Cancer Surgery Innoblative Designs, Inc. has received FDA's IDE approval to begin a study on its SIRA® RFA Electrosurgical Device, aimed at improving breast cancer surgery outcomes.

Innoblative's Innovative Device Gains Approval for Breast Cancer Surgery #United_States #Chicago #Breast_Cancer #Innoblative #SIRA